We enjoyed reading the paper by Kolade et al. 1 on the association of body size indices with central blood pressure and arterial stiffness in healthy individuals and populations with cardiovascular and kidney disease. We congratulate the authors for the meticulous selection of study population subgroups and their excellent work, which demonstrated that although body mass index (BMI) was clearly correlated with central systolic blood pressure (SBP) in apparently healthy individuals, this association was not observed in the subgroups with established vascular disease. What is more, none of the examined body size measures was able to predict arterial stiffness in the healthy control subgroup with relevant data after correcting for brachial BP.
In our opinion, these results may actually add another stone in the pathophysiological foundation of the so-named obesity paradox. Although increased BMI represents a well-acknowledged cardiovascular risk factor aggravating mortality risk in the general population, consistent findings among specific population subgroups with various manifestations of established vascular disease, including those examined in the present study (coronary heart disease, type 2 diabetes mellitus, chronic kidney disease, heart failure, hypertension, peripheral artery disease), support a protective role of overweight towards mortality. Interestingly, a similar role has also been reported in divergent healthier populations. 2 Of note, a recent study on a nationally representative sample demonstrated that being overweight and underweight was associated with a decreased and increased risk for allcause mortality, respectively. 3 With the association between BMI and cardiovascular mortality being eliminated after adjustment for several traditional cardiovascular risk factors, it has been suggested that a substantial part of the BMI-associated risk of cardiovascular mortality is mediated through conventional risk factors. 4 Although the findings of the present study imply a neutral rather than protective effect of obesity on arterial stiffness in healthy and on central hemodynamics in diseased participants, it would be of major interest to determine the impact of increased BMI on the above parameters along with other factors not addressed in the study. When fitness was taken into account, the risk for premature death associated with obesity was paradoxically reversed in middle-aged men with known or suspected coronary artery disease; highly fit overweight men had the lowest mortality risk of any subgroup, including highly fit normal-weight men. 2 Likewise, increased longevity was observed in overweight and obese but fit individuals compared with normal weight but unfit hypertensive men. 5 In the light of this evidence, a separate analysis in the present paper investigating fitness and fatness interactions would be of great use, in case relevant data are available.
Furthermore, it would be useful to examine whether divergent findings are observed according to gender differentiation. Women are more affected by obesity, but cardiovascular disease risk conferred by increased BMI is in general lower compared with men. 6 Whether concomitant medications or coexiting diseases in the disease groups may partially account for the reported outcomes was not clarified. In addition, the relationship between body size measures and brachial and central diastolic BP was not addressed, although relevant data were gathered. 
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